Results 71 to 80 of about 4,588 (118)

Metabolic support of trained immune responses in myeloid cells. [PDF]

Elife
Jarit-Cabanillas A, Dunphy G, Virga F, Van den Bossche J, Sancho D.   +4 more
europepmc   +1 more source

Lysine demethylase 4A: from chromatin to centrosomes. [PDF]

FEBS J
Sharma A, Kearney RM, Morrison CG.
europepmc   +1 more source

DNA, RNA, and histone methylation regulation enzymes and their crosstalk in colorectal carcinogenesis and progression: a review of molecular mechanisms, clinical implications, and future perspectives. [PDF]

Cell Mol Biol Lett
Qian S, Song H, Huang L, Hua H, Zhang X, Li Z, Pu M, Huang H, Zhang J.   +8 more
europepmc   +1 more source

Profiling Inhibitor Scaffolds for the Cancer Target Jumonji-C Domain-Containing Protein 6. [PDF]

ChemMedChem
Corner TP, Salah E, Tumber A, Holt-Martyn JP, Brewitz L, Schofield CJ.   +5 more
europepmc   +1 more source

KDM3A catalyses the oxidation of acetyl-lysine to hydroxyacetyl-lysine on histone H3K9. [PDF]

Nat Chem
Belle R, Bukowski JP, Schiller R, Cutler R, Salah E, Dawber RS, Tumber A, Bonnici J, Kindrick JD, Serrano L, Rabe P, Johansson C, Ruchaud MH, Hopkinson RJ, Figg WD, Brennan PE, Mole DR, Sidoli S, Kawamura A, Schofield CJ.   +19 more
europepmc   +1 more source

[Expression of Concern] Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. [PDF]

Oncol Rep
Lu DH, Yang J, Gao LK, Min J, Tang JM, Hu M, Li Y, Li ST, Chen J, Hong L.   +9 more
europepmc   +1 more source

KDM4B/DHX9 promotes chemoresistance in small-cell lung cancer through the MYCN-driven signaling pathway. [PDF]

Oncogene
Lyu Q, Liu H, Shen W, Lin Z, Zhang Y, Ying H, Long Q, Cao X, Zhang J, Shi J, Qiu Z.   +10 more
europepmc   +1 more source

Genome-wide comparative analysis of the JmjC gene family in <i>Setaria italica</i> and <i>Setaria viridis</i> reveals transcriptional divergence and stress-responsive candidates. [PDF]

Front Plant Sci
Shi W, Ma M, Cao Y, Yan Z, Qiao X, Cheng Y.   +5 more
europepmc   +1 more source

Nitric oxide-driven Warburg reprogramming at the NOS2-COX2 axis: An integrative engine of cancer hallmarks. [PDF]

Redox Biol
Coutinho LL, Palmieri EM, Ridnour LA, Cheng RYS, Heinz WF, Anderson SK, Billiar TR, Chang J, Lockett SJ, Rangel MC, Thomas DD, McVicar DW, Wink DA.   +12 more
europepmc   +1 more source

Epigenetic crossroads in intervertebral disc degeneration: Unlocking novel therapeutic avenues (Review). [PDF]

Mol Med Rep
Hou Y, Liu L, Guo Y, Shi J.
europepmc   +1 more source